The findings indicate that loss of SALL2 in CRC cells is linked to changes in the expression of important Wnt pathway regulators, implying a connection between SALL2 and the suppression of the Wnt/β-catenin pathway. This evidence concerns the gene SALL2 and colorectal carcinoma.